Tower Research Capital »

Generate Biomedicines Ord shares owned by Tower Research Capital

Quarter-by-quarter ownership of Generate Biomedicines Ord (GENB) shares owned by Tower Research Capital from 13F filings

Historical chart of Tower Research Capital investment in Generate Biomedicines Ord

Tip: Access up to 7 years of quarterly data

All positions including Generate Biomedicines Ord held by Tower Research Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Generate Biomedicines Ord by Tower Research Capital

Quarter filed Position value Share count Share price at filing
2026-03-31 $12 1 12.00

More positions owned by Tower Research Capital

Invesco Qqq Tr Unit Ser 1 (QQQ)
Direxion Shares Etf Trust Daily Semiconduc (SOXL)
Apple (AAPL)
Microsoft Corporation (MSFT)
Micron Technology (MU)
Tesla Motors (TSLA)
NVIDIA Corporation (NVDA)
Broadcom (AVGO)
Alphabet Inc Cap Stk Cl A (GOOGL)
Ishares Tr Core Us Aggbd Et (AGG)
State Str Spdr S&p 500 Etf T Tr Unit (SPY)
Vaneck Etf Trust Pharmaceutcl Etf (PPH)
Amazon (AMZN)
JPMorgan Chase & Co. (JPM)
Meta Platforms Cl A (META)

View all positions for Tower Research Capital

Top funds holding Generate Biomedicines Ord

Flagship Ventures Management
FMR
Capital World Investors
Braidwell
Arch Venture Corp
HarbourVest Partners
Baker Bros. Advisors
Harvard Management Company
Nvidia Corp
Siren
Davern Capital Partners
Alyeska Investment Group
ARK Investment Management
Millennium Management
UBS Group

View all funds holding Generate Biomedicines Ord